Verus Capital Partners, LLC Gilead Sciences, Inc. Transaction History

Verus Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $171,193 - $245,774	2,747 New	2,747 $235,000
Q1 2022 Aug 09, 2022	SELL	$57.92 - $72.58 $385,457 - $483,019	-6,655 Closed	0 $0
Q1 2020 May 26, 2020	BUY	$62.63 - $80.22 $198,411 - $254,136	3,168 Added 90.85%	6,655 $498,000
Q4 2019 Feb 27, 2020	BUY	$61.62 - $67.78 $214,868 - $236,348	3,487 New	3,487 $227,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Verus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Verus Capital Partners, LLC with notifications on news.